TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation
CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom, April 7, 2026 /PRNewswire/ — TriNetX, the world’s leading federated health data network, today announced that it has acquired the key assets of Zetta Genomics, a Cambridge, UK-based healthcare technology company and current TriNetX partner. The acquisition expands TriNetX’s genomics data management and analytics capabilities, supporting federated capture of multiomic data. This accelerates healthcare providers’ ability to integrate phenotypic and multiomic data for improved care delivery and clinical research and enhances the ability of TriNetX’s life science customers to perform large-data research in a cost-effective manner.
Zetta’s flagship platform, XetaBase, is a multiomic capture and analytics platform designed for population‑scale genomic analysis. XetaBase is currently in use by leading healthcare provider organizations, life sciences companies, and research institutes.
TriNetX and Zetta have worked closely together since 2024 as part of TriNetX’s genomics data program. During this collaboration, the companies completed substantial technical feasibility work demonstrating secure, federated querying across genomic and phenotypic data to deliver high-integrity, analytically robust insights. This work establishes a strong foundation for further expansion.
“Through our partnership activities, led by our Chief Operating Officer Steve Kundrot and team, we have developed deep familiarity with Zetta’s leadership, technological prowess, and fit-for-purpose approach and have been consistently impressed with Zetta’s trusted healthcare provider relationships and robust analytics platform,” said Jeff Margolis, Executive Chairman of TriNetX. “Welcoming Zetta’s XetaBase platform into the TriNetX ecosystem represents an important milestone for our organization.”
Mr. Margolis continued, “This acquisition reflects our commitment to advancing multiomic-enabled research and supporting healthcare providers with a practical, localized approach to scaling their data infrastructures.”
Jeffrey Brown, PhD, TriNetX Chief Scientific Officer added, “Our purpose of driving better human health through data is clearly enhanced by adding the XetaBase technology, as we strongly believe the integration of different data types is essential to clinical and scientific progress.”
“I am proud of what the Zetta team has built and excited to see XetaBase become part of the TriNetX array of data, software, and intelligence capabilities,” said Ignacio Medina Castello, Chief Executive Officer and Chief Technology Officer of Zetta Genomics. “From the beginning, our collaboration with TriNetX demonstrated that genomic and clinical data can be securely connected in a federated way at scale. Fully joining forces with TriNetX allows that work to move forward faster and to reach a broader global community of healthcare and research partners.”
About TriNetX, LLC
TriNetX is The Global Truth Engine for Better Human Health™, helping organizations understand what’s really happening in patient care. We connect health systems, researchers, and companies around the globe to real‑world patient data so they can make better‑informed decisions—based on reality, not assumptions.
Data is sourced directly from 11,000+ healthcare provider sites across more than 20 countries and kept within those institutions to protect accuracy, privacy, and trust. TriNetX combines this data with scientific expertise and technology to help customers ask better questions, interpret results, and move forward with confidence.
-Fixed–dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study. The fixed dose combination had excellent oral bioavailability, drug exposure and a half-life of up to 12 hours. These data support ASC30_39 FDC tablets as a potential novel one-pill-once-daily therapy for obesity.
-ASC30_39 FDC demonstrated excellent compatibility between ASC30 and ASC39 when combined together, with room temperature stability and a small pill size.
-ASC30 is a Phase III-ready oral small molecule GLP-1R agonist that had a favorable gastrointestinal (GI) profile with half the rate of vomiting vs. orforglipron, when both drugs are dosed with weekly titration.
-ASC39, an oral small molecule amylin-selective amylin receptor agonist, demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models.
-Submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ASC30_39 FDC oral tablets is expected in the third quarter of 2026.
HONG KONG, April 7, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces that it has selected ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30, once-daily oral small molecule GLP-1R agonist and ASC39, once-daily oral small molecule amylin-selective amylin receptor agonist, for clinical development. Ascletis expects to submit an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for ASC30_39 FDC oral tablets for the treatment of obesity in the third quarter of 2026.
ASC30_39 FDC tablets, dosed orally in dogs, demonstrated excellent oral bioavailability, high drug exposure and a long half-life of up to 12 hours. These key parameters of ASC30_39 FDC tablets are consistent with those observed in their respective monotherapies in a head-to-head dog study. Furthermore, ASC30_39 FDC tablets, developed utilizing Ascletis’ proprietary formulation technology, demonstrated a good compatibility between ASC30 and ASC39 with room temperature stability and a small pill size. The combination of the excellent pharmacokinetic profile of ASC30_39 FDC, the potential best- in-class efficacy and gastrointestinal (GI) tolerability of ASC30 and the first eloralintide-like small molecule amylin support ASC30_39 FDC tablets as a potential novel one-pill-once-daily therapy for the treatment of obesity.
ASC30 is a Phase III-ready oral small molecule GLP-1R agonist that had a favorable gastrointestinal (GI) profile with half the rate of vomiting vs. orforglipron, when both drugs are dosed with weekly titration in non-head-to-head studies (Press release).
As a clinical development candidate, ASC39 is a potent and amylin-selective oral small molecule amylin receptor agonist and demonstrated eloralintide-like amylin selectivity and efficacy in preclinical models.
“Selection of this fixed dose combination, which we believe is the first publicly announced co-formulation of an oral GLP-1 and an oral amylin, is an important step in the development of a new oral, potentially synergistic combination of ASC30 and ASC39 for the treatment of obesity,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis. “We believe this fixed dose combination, which combines the key features of high bioavailability, high drug exposure, a long half-life, and the convenience of a small pill, has the opportunity to improve patient outcomes for the treatment of obesity.”
About Ascletis Pharma Inc.
Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug candidates in-house, including both small molecules and peptides, such as its lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, an amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist and ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, and ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist, for chronic weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).
CHANGZHOU, China, April 7, 2026 /PRNewswire/ — Jin Medical International Ltd. (NASDAQ: ZJYL) (“Jin Medical”, and together with all its subsidiaries and consolidated entities, the “Company“), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement.
The Company regained compliance after its Class A ordinary shares maintained a closing bid price of at least $1.00 per share for more than ten (10) consecutive business days.
The Company will continue to focus on its core business operations and ongoing strategic initiatives.
About Jin Medical International Ltd.
Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit: http://www.jinmed.com.
Forward-Looking Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may”, “will”, “should”, “intend”, “plan”, “strive”, “believe”, “expect”, “anticipate”, “project”, “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions, fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC“). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
TAIPEI, April 7, 2026 /PRNewswire/ — Cathay Financial Holdings (Cathay FHC) today announced a long-term strategic collaboration with OpenAI to strengthen the Group’s core capabilities in AI research, deployment, and governance. Cathay FHC is the first financial institution organization to work with OpenAI at this scale to bring AI advanced capabilities into its operations in Taiwan.
Cathay Financial Holdings announces a landmark long-term partnership with OpenAI, becoming the first financial institution in Taiwan to integrate advanced AI at this scale across research, deployment, and governance. (Resource: Cathay Financial Holdings)
As artificial intelligence reshapes industries worldwide, financial institutions are increasingly exploring how advanced AI can transform internal operations, strengthen decision-making, and enhance customer services.
Under this agreement, Cathay FHC will deploy ChatGPT Enterprise across its subsidiaries and equip its employees with secure, enterprise-grade AI tools that are built with security and regulatory compliance. The roll-out will support teams in their day-to-day work while accelerating the development of new AI powered applications.
“Cathay FHC will leverage OpenAI’s technologies and engineering expertise to progressively introduce Agentic AI into our existing financial workflows. This will deepen intelligent and automated applications across business scenarios and support the transformation of our operating models,” said Marcus Lopez, Chief Technology Officer of Cathay Financial Holdings. “In addition, both parties will develop structured training and enablement programs to strengthen employees’ AI proficiency, enabling AI to become an effective digital teammate that elevates operational performance and modernizes workplace practices.”
“Cathay FHC has a clear vision for bringing advanced AI into the financial sector in a responsible and innovative way. We look forward to working together to roll out ChatGPT Enterprise and build secure, compliant solutions that help their teams move faster and deliver better outcomes for their customers,” said Oliver Jay, Managing Director, International of OpenAI.
A key focus of this collaboration is the creation of an enterprise-grade AI workstation that integrates OpenAI’s advanced large language model capabilities with Cathay FHC’s internal knowledge bases and proprietary intelligent agents. The platform will deliver a scalable, governable intelligent work environment and AI assistants for employees. It will enhance knowledge processing and day-to-day operations such as document summarization and rewriting, data synthesis, presentation generation, and operational inquiries. The workstation will also support natural-language-based code generation to accelerate engineering development and business automation. Secure integration with existing enterprise systems will further streamline workflow connectivity and improve information accessibility.
In addition to deploying ChatGPT Enterprise, Cathay FHC is also using OpenAI’s API to build new AI applications. Two initial initiatives focus on developing agentic AI systems for corporate banking and insurance. OpenAI will extend its technical experts to build an intelligent agent engine capable of multi-agent orchestration, along with a continuously evolving financial-domain knowledge system. These advancements will enhance operational efficiency while strengthening risk management and decision transparency, ensuring that all applications meet rigorous regulatory and compliance requirements.
Looking ahead, Cathay FHC will remain customer-centric and also advance an “AI as a Service” (AIaaS) approach, embedding AI significantly into employee workflows, service processes, and financial products. With a strong foundation of security and resilience, Cathay FHC will continue collaborating with strategic partners to shape a forward-looking, robust blueprint for next-generation digital finance.
VICTORIA, Seychelles, April 7, 2026 /PRNewswire/ — MEXC, the world leader in 0‑fee digital asset trading, has listed two Ondo tokenized stock trading pairs on its spot market, tied to leading quantum computing companies. The move further expands the range of real-world assets (RWA) available to users on the platform.
MEXC Lists Two Ondo Tokenized Stock Trading Pairs Tied to Quantum Computing Sector
IONQON/USDT and RGTION/USDT were listed on April 6, 2026, at 12:00 UTC. Withdrawals are enabled from April 7, 2026, at 12:00 UTC.
IONQON and RGTION represent tokenized versions of IonQ and Rigetti Computing, two publicly listed pure-play quantum computing companies at the forefront of a sector gaining increasing commercial momentum. Both tokens are issued through Ondo Global Markets, a platform designed to bring traditional public securities onchain, with tokens that are freely transferable and usable in DeFi.
The listings reflect MEXC’s broader commitment to serving as a bridge between traditional financial markets and the digital asset ecosystem. By integrating tokenized real-world assets into its platform, MEXC enables users to access infinite opportunities across diverse markets within a single interface. Guided by a user-centered approach, MEXC continues to enhance its platform, ensuring users have timely and efficient access to relevant trading solutions as markets evolve.
About MEXC
Founded in 2018, MEXC is committed to being “Your Easiest Way to Crypto.” Serving over 40 million users across 170+ countries, MEXC is known for its broad selection of trending tokens, everyday airdrop opportunities, and low trading fees. Our user-friendly platform is designed to support both new traders and experienced investors, offering secure and efficient access to digital assets. MEXC prioritizes simplicity and innovation, making crypto trading more accessible and rewarding.
This content does not constitute investment advice. Given the highly volatile nature of the cryptocurrency market, investors are encouraged to carefully assess market fluctuations, project fundamentals, and potential financial risks before making any trading decisions.
BEIJING, April 7, 2026 /PRNewswire/ — During a recent industry event in Beijing, China, EVE Energy announced multiple major advances in the energy storage sector. The company officially launched its next-generation 6.9MWh large-format battery energy storage system (BESS), held a certification ceremony for its 628Ah large-format battery system passing a large-scale fire test by an internationally recognized authority, and signed strategic cooperation agreements totaling over 50GWh for its large-format batteries.
6.9MWh System Global Debut: Focus on Efficiency and Safety
The newly launched 6.9MWh BESS, the latest addition to EVE Energy’s Mr.Big Family, is built on the company’s mature battery platform. Housed in a standard 20-foot container, the system achieves a 10% increase in energy density compared to previous generations, with cell-level volumetric energy density exceeding 430Wh/L. Through structural optimization, its footprint is reduced by 6%, saving approximately RMB 2.6 million in initial investment per station. The system delivers 10,000 cycles at 70% state of health (SOH), with temperature differential kept within 5°C using active balancing and precision thermal management. On the safety front, the system features 1,500V DC full-voltage five-level protection and an active safety solution combining AI, multi-detection, and staged fire suppression, enabling closed-loop management from early warning to fire control.
Certified by International Large-Scale Fire Test, Safety Validated
Alongside the exhibition, CSA Group presented EVE Energy with a certificate for passing a large-scale fire test on its 628Ah large-format battery and 5MWh BESS. The test strictly followed international standards including CSA/ANSI C800:25, UL 9540A, and NFPA 855, verifying the system’s fire safety and thermal runaway control under extreme fire conditions. Additionally, EVE Energy’s 261kWh outdoor integrated storage cabinet received CB, CE, and AS certifications from SGS, while the S6900 BESS obtained CB and CE certifications, providing a solid compliance foundation for further overseas market expansion.
Over 50GWh in Deals, Deepening Cooperation with Industry Leaders
During the event, EVE Energy signed strategic cooperation agreements with five leading industry players: Beijing Goldwind Zero Carbon Energy Co., Ltd., Zhejiang Jinko Energy Storage Co., Ltd., Jiangsu Linyang Energy Equipment Co., Ltd., China Energy Construction Energy Storage Technology (Wuhan) Co., Ltd., and Shanghai Ronghe Yuan Energy Storage Co., Ltd.. The partnerships focus on large-format batteries and core energy storage products, with total contracted volume exceeding 50GWh.
With its new product launch, safety certifications, and large-scale orders, EVE Energy has further demonstrated its technological expertise and market strength in the large-format battery storage segment. The company stated that it will continue to deepen its core capabilities in high-capacity energy storage and work with global partners to drive the development of the energy storage industry ecosystem.
HOI AN, Vietnam, April 7, 2026 /PRNewswire/ — For a destination long defined by its preserved old town and cultural charm, Hoi An has rarely been positioned on the global stage of contemporary luxury. That narrative is beginning to shift. With its recent recognition at the Luxury Lifestyle Awards as Best Luxury Heritage Resort, Grand Signature Resort Hoi An by M Village marks a significant milestone – becoming the first resort in Hoi An to be honored in the luxury heritage category.
Grand Signature Resort Hoi An by M Village Earns Global Recognition
A Peaceful Heritage Village for a Soulful Retreat
Set within the heart of Hoi An, just moments from the ancient town, Grand Signature Resort introduces a distinct concept: a “Peaceful Heritage Village” designed for a more soulful kind of retreat. Here, heritage is not presented as something to observe, but something to live within. The experience is shaped around a holistic sense of balance, where body, mind and spirit are gently restored through a slower, more intentional rhythm of living.
Designed to Be Lived, Not Just Experienced
Inspired by the traditional villages of Quang Nam, the resort unfolds through timber structures, tiled roofs and serene landscapes. Guests move through the space on foot or by bicycle, mirroring the rhythm of a local neighborhood.
Positioned near some of the region’s most beloved cultural villages, it draws from the craft of Kim Bong woodwork, the earthiness of Thanh Ha pottery, and the greenery of Tra Que – long favored by international travelers seeking a deeper connection to Hoi An’s living heritage.
Discover Hoi An’s First Luxury Heritage Resort
A Slower Rhythm of Travel
What defines the experience is not a list of activities, but the way time is felt. Mornings arrive softly, with natural light filtering through garden spaces. Days stretch between moments of movement and stillness – whether wandering through the surrounding streets or retreating into private corners. Evenings settle into a calm, unhurried atmosphere, where the boundaries between space, culture and personal experience begin to dissolve.
A serene village retreat set in the heart of Hoi An
Hospitality Rooted in Human Connection
At the heart of the resort is its service philosophy, “Villager Care,” which reimagines hospitality as something more intuitive and human. Guests are welcomed not as visitors passing through, but as part of a living community – where care is personal, unforced, and rooted in a genuine sense of belonging.
Redefining How Hoi An Is Experienced
This approach sets Grand Signature Resort Hoi An apart within Hoi An’s increasingly competitive hospitality landscape. Rather than offering a curated version of heritage, it presents a living environment shaped by culture, rhythm and connection. In doing so, it shifts the perception of Hoi An from a destination to visit briefly, into a place that invites a deeper, more sustained way of experiencing.
Complementing an orchard-themed dreamy tea set by two master pâtissiers, a series of fascinating delicacies is presented by Galaxy Macau in April
MACAU SAR – Media OutReach Newswire – 7 April 2026 -In celebration of its ascent to One Diamond status in China’s prestigious Black Pearl Restaurant Guide, Galaxy Macau’s Japanese fine‑dining destination Yamazato proudly unveils the Black Pearl Tasting Kaiseki — a refined and contemplative culinary expression that honours seasonality, precision and the quiet elegance intrinsic to Japanese haute cuisine. Framed by sweeping panoramic views across Galaxy Macau landscape, the experience captures the fleeting beauty of nature through an artful and disciplined gastronomic lens.
Yamazato celebrates its Black Pearl One Diamond distinction with a contemplative kaiseki by Executive Chef Hideaki Hayashi, where seasonal purity, meticulous craftsmanship, and serene vistas converge to distil the quiet poetry of Japanese haute cuisine.
At the helm, Executive Chef Hideaki Hayashi and his culinary team invite guests on a pristine gastronomic journey shaped by meticulous craftsmanship and profound reverence for ingredients. Each kaiseki course is composed with thoughtful intentions, drawing upon the season’s finest offerings, be it produce from the sky, the sea and the land. Every detail — subtle aroma, layered texture, nuanced flavours, and elegant presentation — is harmoniously orchestrated to awaken the senses and express the restrained poetry at the heart of Japanese culinary artistry.
The Black Pearl Tasting Kaiseki is priced at MOP 1,980+ per guest and is available Tuesday to Sunday, from 5:30 pm to 10:00 pm.
Floral Tea Set in the Orchard Setting of CHA BEI
This spring and summer, Galaxy Macau unveils an enchanting new afternoon tea experience at CHA BEI, co‑created by Executive Pastry Chef Yam Lok Hin and internationally revered Meilleur Ouvrier de France Pâtissier 2023 Pierre‑Henri Roullard. Inspired by a radiant garden in full bloom, the Orchard in Bloom afternoon tea invites guests on a refined journey through delicately balanced savoury and sweet creations, infused with flowers, fruits and tea leaves. Within the serene surroundings of CHA BEI, the brilliance of the spring and summer season is reimagined as a tranquil, storybook orchard, where flavour and artistry flourish in harmony.
Galaxy Macau’s Orchard in Bloom at CHA BEI is a poetic afternoon tea by Lok Hin Yam and Pierre‑Henri Roullard, where florals, fruits and tea leaves coalesce in refined seasonal harmony.
The experience opens with Lavender Breeze, a graceful floral welcome that sets the tone for a series of garden‑inspired delights, where seasonal ingredients are transformed into elegant edible jewels. Bright citrus notes, sun‑ripened fruits and fragrant botanicals come together across exquisite pastries and artfully crafted savouries, each reflecting meticulous craftsmanship and creative imagination. Available throughout spring and summer, this inspired collaboration blossoms as a celebration of colour, texture and taste — where two distinct pastry visions unite in a symphony of refined indulgence.
Priced at MOP598+ for two, “Orchard in Bloom” afternoon tea will be available between 2:30pm and 5:30pm every day, from now until August 31.
Alongside these sumptuous delicacies, Galaxy Macau has prepared a series of fascinating dining promotions this April and beyond:
• April 9
Blossom Palaces –
“Huaiyang Spring Feast: A Symphony of Two Masters” Four-hands Gala
The refined artistry of Huaiyang cuisine takes centre stage as Blossom Palaces Founder Bobby Lo and Macau Chef de Cuisine Ricky Wu unite for an elegant spring dinner. From tea‑infused starters to signature wood‑fired Peking duck, the evening is elevated by a live tea‑frying performance celebrating tradition, aroma and seasonal finesse.
Time: 6pm – 9pm
Price: MOP1,088/person
Huaiyang cuisine takes the spotlight as Blossom Palaces Founder Bobby Lo joins Macau Chef de Cuisine Ricky Wu for a refined spring dinner, featuring tea‑infused starters, signature wood‑fired Peking duck and a live tea‑frying performance celebrating tradition and seasonal grace.
• April 10 & 11
Saffron –
“A Royal Symphony of Thai Cuisine”
Saffron marks Songkran Festival with an elegant celebration of Thai New Year, featuring a rare collaboration between Executive Chef Jan Ruangnukulkit and Chef Chumpol Jangpra, the brain behind Bangkok’s two-Michelin-starred R‑HAAN. The immersive experience blends ceremonial rituals, cultural performances and a masterfully curated tasting menu honouring tradition, artistry and renewal.
Price: MOP1,688/person (additional MOP300 for wine pairing)
Saffron marks Songkran Festival with an elegant celebration that seamlessly blends ceremonial rituals, cultural performances and a masterfully curated tasting menu – honouring Thai tradition, culinary artistry and the spirit of renewal.
• April 18 & 19
8½ Otto e Mezzo BOMBANA –
The Grand Bombana Feast
In celebration of Italian cuisine’s recognition as UNESCO Intangible Cultural Heritage, Chef Umberto Bombana unites his protégés from Michelin‑starred kitchens across Asia for an unprecedented gastronomic gathering. Each chef presents a personal interpretation shaped by heritage and mentorship, creating an elegant dialogue between timeless Italian tradition and contemporary global expression—an exceptional feast and a living culinary legacy.
Date: April 18, 2026 (dinner)│ April 19, 2026 (lunch and dinner)
Price: Lunch Tasting Menu MOP1,680/person (additional MOP980 for wine pairing)
Dinner Tasting Menu MOP3,280/person (wine-pairing for an additional MOP1,880)
In celebration of Italian cuisine’s recognition as UNESCO Intangible Cultural Heritage, Chef Umberto Bombana unites his protégés from Michelin‑starred kitchens across Asia for an unprecedented gastronomic gathering at 8½ Otto e Mezzo BOMBANA at Galaxy Macau.
• April 25 & 26
Andaz Kitchen –
Chinese-Portuguese Master Chefs Four-Hands Dinner Series · Chapter 2
Andaz Macau’s Executive Chef André Lai joins hands with Chef Larry Liu of Shenzhen’s Black Pearl One-Diamond restaurant, CHINA LODGE, for a refined culinary exchange celebrating the dialogue between Chinese tradition and Portuguese heritage. Guided by the Cantonese principles of seasonality and purity of flavours, Chef Liu brings his thoughtful craftsmanship and contemporary interpretation of Cantonese cuisine – deeply rooted in respect for ingredients and culinary legacy – resulting in an inspired collaboration that bridges cultures through taste.
Price: MOP1,088/person (wine pairing included)
• Daily
Kyo Watami –
Triple Don Indulgence
Kyo Watami’s seafood don trio invites diners to savour three bowls of Japanese favourites, each layered with seasonal seafood over steamed rice. From luxurious sea urchin and tuna, to salmon roe with sashimi, and sweet soy‑glazed grilled eel with omelette, the set is completed with a light salad and comforting soup.
Price: MOP128/set
Date: Daily during lunch hours
A Month of Global Mixology Encounters at Galaxy Macau
International symphonies of mixology continue at Galaxy Macau’s three acclaimed venues – Pony & Plume, Long Bar and Ritz-Carlton Bar & Lounge.
On April 9, Capella at Galaxy Macau’s Pony & Plume will welcome star mixologist KT Lam for the second chapter of “The Finest Pour” series. Leader of the bars at Rosewood Bangkok and having led DarkSide at Rosewood Hong Kong to No. 9 on Asia’s 50 Best Bars in 2023, KT will present four cocktails at Macau’s newest must-visit bar—each a distillation of his decade-long journey in mixology, inspired by the cities that have shaped him, capturing their energy, harmony, and contrasts.
On April 9, Capella at Galaxy Macau’s Pony & Plume will welcome star mixologist KT Lam who will shine with the distillation of his decade-long journey in mixology.
On April 11, the Ritz-Carlton Bar and Lounge at The Ritz-Carlton, Macau anticipates guests to savour an evening of “The Alchemist Flair: A Global Mixology Experience with Chase White”, as founder of Bar Blanc in Shanghai, and botanical spirits label OFBT, mixologist Chase White instils his passion and adventurous spirit into his creations, which champion a philosophy of “restrained creativity” and celebrate balance, quality, and simplicity—without sacrificing intrigue.
Long Bar at Raffles at Galaxy Macau welcomes Jo Lo and Birstacla Wong, co‑owners of Hong Kong’s acclaimed cocktail bar Bar Mind, for the April edition of Adventures in the Cavern. The award‑winning mixology duo—both past recipients of Diageo World Class Hong Kong & Macau Bartender of the Year—will present an evening of innovative cocktails that blend heritage flavours with contemporary techniques. The guest shift takes place on April 25, offering guests an inspired journey into modern mixology.
The issuer is solely responsible for the content of this announcement.
ABOUT GALAXY MACAU INTEGRATED RESORT
Galaxy Macau, The World-class Luxury Integrated Resort delivers the “Most Spectacular Entertainment and Leisure Destination in the World”. Developed at an investment of HK$43 billion, the property covers 1.1 million-square-meter of unique entertainment and leisure attractions that are unlike anything else in Macau. Nine award-winning world-class luxury hotels provide close to 5,000 rooms, suites and villas. They include Banyan Tree Macau, Galaxy Hotel, Hotel Okura Macau, JW Marriott Hotel Macau, The Ritz-Carlton, Macau, Broadway Hotel, Raffles at Galaxy Macau, Andaz Macau, and Capella at Galaxy Macau. Unique to Galaxy Macau, the 75,000-square-meter Grand Resort Deck features the world’s longest Skytop Adventure Rapids at 575-meters, the largest Skytop Wave Pool with waves up to 1.5-meters high and 150-meters pristine white sand beach. Two five-star spas from Banyan Tree Spa Macau and The Ritz- Carlton Spa, Macau help guests relax and rejuvenate.
As the dining destination in Asia, Galaxy Macau offers a wide variety of gastronomic delights, exquisite experiences and ingredients of the finest quality with over 120 dining options from Michelin dining to authentic delicacies.
Embark on a delightful and rewarding journey at Galaxy Promenade, the one-stop shopping destination boasting some of the world’s most iconic luxury brands. Be the first to get the latest limited-edition items; explore fascinating pop-ups by coveted labels and revel in fabulous shopping rewards and privileges. Our VIPs are entitled to a highly-curated experience with dedicated personal shoppers at guests’ service, and be invited to exclusive luxury brand events. A different caliber of privileges and rewards also await. Discover the joys of fashion and stand at the forefront of style and sophistication—Galaxy Promenade has everything guests need to stay ahead of the style game.
Galaxy Cinemas takes immersive movie experiences to the next level with the latest audio-visual technology, ultra-luxurious facilities and bespoke services; CHINA ROUGE, one-of-a-kind cabaret lounge that evokes the glamor of Shanghai’s golden era with stylish entertainment and customizable surrounds; and Foot Hub, which presents the traditional art of reflexology for authentic relaxation and revitalization. For Authentic Macau Flavours and Vibrant Asian Experiences, Broadway Macau – just a 90-second walk via a bridge from Galaxy Macau, has over 35 Authentic Macau & Asian Flavours at Broadway Food Street. The 2,500-seat Broadway Theatre plays host to world-class entertainers and a diverse array of cultural events.
Meeting, incentive and banquet groups are also catered to with a portfolio of unique venues in Galaxy Macau and an expert service team. Galaxy International Convention Center (GICC) is the latest addition to the Group’s ever-expanding integrated resort precinct and will usher in a new era for the MICE industry in Macau. GICC is a world-class event venue featuring 40,000-square-meters of total flexible MICE, and the 16,000-seat Galaxy Arena – the largest indoor arena in Macau.
www.galaxymacau.com
